CHRISTOPHER SMITH: Open Payments
NPI 1548206725 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 59 payments from 9 companies in 2025. Trend: 2023 $855 · 2024 $836 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $206 |
| Philips North America LLC | 6 | $181 |
| Amgen Inc. | 10 | $170 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 15 | $158 |
| E.R. Squibb & Sons, L.L.C. | 7 | $119 |
| PFIZER INC. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LEQVIO, Ambulatory Monitoring & Diagnostics Undivided, REPATHA, LifeVest, ELIQUIS, JARDIANCE, CAMZYOS, VYNDAQEL.
Industry payments across SC — which companies pay providers there.
